SCHEMBL854153

SCHEMBL854153

CCOC(=O)CC(=O)c1cccc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 2/20 0.60
CDC25A P30304 1/20 0.56
CDC25C P30307 1/20 0.56
ALDH1A1 P00352 4/20 0.56
KDM4E B2RXH2 4/20 0.56
PTPN1 P18031 1/20 0.54
HPGD P15428 3/20 0.54
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
POLB P06746 3/20 0.51
GMNN O75496 2/20 0.51
LMNA P02545 2/20 0.51
MAPT P10636 2/20 0.51
MAPK1 P28482 2/20 0.51
BLM P54132 2/20 0.51
PMP22 Q01453 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
CMKLR1 Q99788 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
TSHR P16473 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6926548 0.85 PTPN1 (0.59) CDC25BALDH1A1KDM4EPTPN1HPGD
SCHEMBL20913014 0.85 CDC25B (0.57) CDC25BCDC25ACDC25CALDH1A1KDM4E
SCHEMBL11377550 0.82 KMT2A (0.52) CDC25BCDC25ACDC25CALDH1A1KDM4E
SCHEMBL3382171 0.82 CNR1 (0.60) CDC25BCDC25ACDC25CALDH1A1KDM4E
SCHEMBL11085302 0.81 CDC25B (0.53) CDC25BCDC25ACDC25CALDH1A1KDM4E
SCHEMBL5857951 0.81 PTPN1 (0.71) CDC25BALDH1A1KDM4EPTPN1HPGD
SCHEMBL29457006 0.81 PTPN1 (0.71) CDC25BALDH1A1KDM4EPTPN1HPGD
SCHEMBL10641793 0.81 CYP3A4 (0.51) CDC25BALDH1A1KDM4EPTPN1HPGD
SCHEMBL406193 0.80 ERCC5 (0.59) ALDH1A1KDM4EMEN1KMT2APOLB
SCHEMBL277672 0.80 CDC25B (0.82) CDC25BCDC25ACDC25CALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105523874-A Preparation method of 2,2-dihalo-1,3-dicarbonyl derivatives ZHANGJIAGANG INST IND TECHNOLOGIES SOOCHOW UNIV 2016-04-27 CN claimed
CN-105503635-A Preparation method for 2-amidoformyl-1,3-dicarbonyl derivative UNIV SOOCHOW 2016-04-20 CN claimed
CN-105461496-A Preparation method for 2-halogenated-1,3-dicarbonyl derivative CHINASUN SPECIALTY PRODUCTS CO LTD 2016-04-06 CN claimed
EP-3954685-B1 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF US HEALTH (US) 2025-08-27 EP disclosed
US-12365653-B2 Small molecule inhibitors of lactate dehydrogenase and methods of use thereof THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC (US) 2025-07-22 US disclosed
US-20240368087-A1 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2024-11-07 US disclosed
US-11897845-B2 Small molecule inhibitors of lactate dehydrogenase and methods of use thereof THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-02-13 US disclosed
US-20220220078-A1 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2022-07-14 US disclosed
CN-107624112-B Small molecule inhibitors of lactate dehydrogenase and methods of use thereof 美国政府健康及人类服务部 2022-03-04 CN disclosed
EP-3954685-A1 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF The United States Of America, As Represented By The Secretary, Department Of Health And Human Services (US) 2022-02-16 EP disclosed
US-11247971-B2 Small molecule inhibitors of lactate dehydrogenase and methods of use thereof THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2022-02-15 US disclosed
US-RE30739-E ANTIDEPRESSANT BEECHAM GROUP LIMITED (GB) 1981-09-08 US disclosed
US-4234726-A ANOREXIGENIC AGENTS, MOOD MODIFIERS BEECHAM GROUP LIMITED (GB) 1980-11-18 US disclosed
US-4167515-A Anorexic chromans BEECHAM GROUP LIMITED (GB) 1979-09-11 US disclosed
US-4153617-A Anorexic chromans BEECHAM GROUP LIMITED (GB) 1979-05-08 US disclosed
US-4148909-A Chromans to treat depression and reduce appetite BEECHAM GROUP LIMITED (GB) 1979-04-10 US disclosed
US-4146539-A MOOD MODIFYERS, ANTIDEPRESSANTS BEECHAM GROUP LIMITED (GB) 1979-03-27 US disclosed
US-4133883-A Polycyclic chromenes useful as antidepressants and anorexics BEECHAM GROUP LIMITED (GB) 1979-01-09 US disclosed
US-4080335-A Anorexic chromans BEECHAM GROUP LIMITED (GB) 1978-03-21 US disclosed
US-3950525-A BRONCHODILATION, 4-HYDROXY-6-ARYL PYRIMIDINES PFIZER INC. (US) 1976-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11247971-B2 Small molecule inhibitors of lactate dehydrogenase and methods of use thereof LDHB, LDHA, PDHB CDC25B 1135/4885CDC25A 778/4885CDC25C 2089/4885
US-11897845-B2 Small molecule inhibitors of lactate dehydrogenase and methods of use thereof LDHB, LDHA, PDHA1 CDC25B 1413/4885CDC25A 893/4885CDC25C 2275/4885
US-12365653-B2 Small molecule inhibitors of lactate dehydrogenase and methods of use thereof LDHB, LDHA, PDHA1 CDC25B 1413/4885CDC25A 893/4885CDC25C 2275/4885
US-20240368087-A1 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF LDHB, LDHA, PDHA1 CDC25B 1413/4885CDC25A 893/4885CDC25C 2275/4885
US-20220220078-A1 SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF LDHB, LDHA, PDHA1 CDC25B 1413/4885CDC25A 893/4885CDC25C 2275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.